Application 021004
- Type
- NDA
- Sponsor
- GLAXOSMITHKLINE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EPIVIR-HBV | LAMIVUDINE | SOLUTION;ORAL | 5MG/ML | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021004-001 | EPIVIR-HBV | LAMIVUDINE | 5MG/ML | SOLUTION / ORAL | RLD | 1998-12-08 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | N021004-001 | EPIVIR-HBV | 5MG/ML | SOLUTION / ORAL | RLD, RS | 1998-12-08 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N021004-001 | EPIVIR-HBV | 5MG/ML | SOLUTION / ORAL | RLD, RS | 1998-12-08 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N021004-001 | EPIVIR-HBV | 5MG/ML | SOLUTION / ORAL | RLD | 1998-12-08 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lamivudine | LAMIVUDINE | Camber Pharmaceuticals, Inc. | 6bd6b9da-df69-46db-813e-4e7f3bdecf95 | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| LAMIVUDINE | LAMIVUDINE | Major Pharmaceuticals | 6fd4d6b9-65ea-4988-8d6f-dd220ec5052d | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Strides Pharma Science Limited | ac824c7e-9c9f-487b-ad2f-d50eaef5cbda | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| LAMIVUDINE | LAMIVUDINE | Golden State Medical Supply, Inc. | f3637209-303e-4232-ae79-07315a990973 | 2025-11-24 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| LAMIVUDINE | LAMIVUDINE | Apotex Corp. | 34c02bcc-d6ff-99d4-8e6a-4a91908adca8 | 2025-09-19 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Golden State Medical Supply, Inc. | 3c30216d-f9f5-104b-e063-6294a90af8fd | 2025-08-12 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Apotex Corp. | 87095352-c088-74b1-7be0-d3e293a90611 | 2025-06-17 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Coupler LLC | 2d7db3b2-9b3c-3031-e063-6294a90a342c | 2025-02-06 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| lamivudine | LAMIVUDINE | Camber Pharmaceuticals, Inc. | e90671c6-7fff-48f4-8898-29f02d049c8b | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Camber Pharmaceuticals, Inc. | 49d53e74-3798-4463-b817-1c8beb755034 | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | American Health Packaging | 7ad3a998-8e4d-43a0-8930-8f7a6ae539b4 | 2024-09-16 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Aurobindo Pharma Limited | a8a492ab-396a-4b7c-99b3-bcb6d3386f71 | 2024-04-29 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Rising Pharma Holdings, Inc. | bed2e227-8d36-40ea-bbbf-d8793bfda425 | 2024-04-16 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Aurobindo Pharma Limited | ba7ee31e-e8d4-4e17-b27a-d2ce69e3bb00 | 2024-04-16 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Lupin Pharmaceuticals, Inc. | ff3b5265-f533-4332-a861-d8c9c1664ffd | 2024-01-03 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Macleods Pharmaceuticals Limited | 1be30bcc-2d9f-4afc-8f09-adc840b3f2d9 | 2022-12-01 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Ingenus Pharmaceuticals, LLC | 47f8be59-178c-4bad-96a4-a5c82784f308 | 2018-12-24 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0173-0663 | EPIVIR | lamivudine | GlaxoSmithKline LLC | NDA | Current |
| 0173-0663 | EPIVIR | lamivudine | GlaxoSmithKline LLC | NDA | Current |
| 0173-0663 | EPIVIR | lamivudine | GlaxoSmithKline LLC | NDA | Current |
| 0173-0663 | EPIVIR | lamivudine | GlaxoSmithKline LLC | NDA | Current |
| 0173-0663 | EPIVIR | lamivudine | GlaxoSmithKline LLC | NDA | Current |
| 0173-0663 | EPIVIR | lamivudine | GlaxoSmithKline LLC | NDA | Current |
| 0173-0663 | EPIVIR | lamivudine | GlaxoSmithKline LLC | NDA | Current |
| 0173-0663 | EPIVIR | lamivudine | GlaxoSmithKline LLC | NDA | Current |
| 0173-0663 | EPIVIR | lamivudine | GlaxoSmithKline LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 69777 | SUPPL | 2021-12-27 |
| 69758 | SUPPL | 2021-12-27 |
| 56686 | SUPPL | 2018-12-07 |
| 56548 | SUPPL | 2018-11-23 |
| 49887 | SUPPL | 2017-09-29 |
| 49871 | SUPPL | 2017-09-28 |
| 48342 | SUPPL | 2017-05-10 |
| 48329 | SUPPL | 2017-05-09 |
| 26457 | SUPPL | 2013-12-24 |
| 35861 | SUPPL | 2013-12-23 |
| 26456 | SUPPL | 2011-01-27 |
| 14144 | SUPPL | 2011-01-24 |
| 35860 | SUPPL | 2007-10-04 |
| 4015 | SUPPL | 2007-10-04 |
| 14143 | SUPPL | 2004-12-03 |
| 4013 | SUPPL | 2004-12-02 |
| 35859 | SUPPL | 2004-09-29 |
| 4014 | SUPPL | 2004-09-29 |
| 35858 | SUPPL | 2003-12-01 |
| 26455 | SUPPL | 2003-11-25 |
| 35857 | SUPPL | 2001-08-16 |
| 21348 | SUPPL | 2001-08-16 |
| 4012 | SUPPL | 2001-08-16 |
| 41870 | ORIG | 1998-12-08 |
| 35856 | ORIG | 1998-12-08 |
| 4011 | ORIG | 1998-12-08 |